PlumX Metrics
Embed PlumX Metrics

DTaP-IPV-Hep B-Hib vaccine (Hexyon®/Hexacima®): A guide to its use in the primary and booster vaccination of infants and toddlers in Europe

Drugs and Therapy Perspectives, ISSN: 1172-0360, Vol: 29, Issue: 11, Page: 329-335
2013
  • 13
    Citations
  • 0
    Usage
  • 13
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Citations
    13
    • Citation Indexes
      13
  • Captures
    13

Article Description

Hexyon®/Hexacima® (DTaP-IPV-Hep B-Hib) is a new thiomersal-free hexavalent combination paediatric vaccine indicated for the primary and booster vaccination of infants and toddlers from 6 weeks to 24 months of age in Europe. Clinical data indicate that vaccination with this vaccine is a safe and immunogenic option for providing protection against the serious childhood infections of diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and invasive diseases caused by Haemophilus influenzae type b. Its fully liquid ready-to-use formulation is convenient and simplifies administration by healthcare professionals. © 2013 Springer International Publishing Switzerland.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know